These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12547903)

  • 1. MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation.
    Maeda M; Yamamoto I; Fukuda M; Nishida M; Fujitsu J; Nonen S; Igarashi T; Motomura T; Inaba M; Fujio Y; Azuma J
    Diabetes Care; 2003 Feb; 26(2):547-8. PubMed ID: 12547903
    [No Abstract]   [Full Text] [Related]  

  • 2. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma homocysteine and its determinants in diabetic retinopathy.
    Vaccaro O; Perna AF; Mancini FP; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Diabetes Care; 2000 Jul; 23(7):1026-7. PubMed ID: 10895864
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Chin Med J (Engl); 2003 Jan; 116(1):145-7. PubMed ID: 12667409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes.
    Vaccaro O; Ingrosso D; Rivellese A; Greco G; Riccardi G
    Lancet; 1997 Apr; 349(9058):1102-3. PubMed ID: 9107272
    [No Abstract]   [Full Text] [Related]  

  • 6. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
    Sun J; Xu Y; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients.
    Noiri E; Taguchi J; Nakao A; Fujita T
    Diabetes Care; 2000 Feb; 23(2):260. PubMed ID: 10868846
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes?
    Blüthner M; Brüntgens A; Schmidt S; Strojek K; Grzeszczak W; Ritz E
    Nephrol Dial Transplant; 1999 Jan; 14(1):56-7. PubMed ID: 10052477
    [No Abstract]   [Full Text] [Related]  

  • 9. No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy.
    Yoshioka K; Yoshida T; Takakura Y; Kogure A; Umekawa T; Toda H; Yoshikawa T
    Diabetes Care; 2003 Jun; 26(6):1947-8; author reply 1948. PubMed ID: 12766148
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of polymorphism of methylene-tetrahydro-folate-reductase with urinary albumin excretion rate in type 1 diabetes mellitus but not with preeclampsia, retinopathy, and preterm delivery.
    Lauszus FF; Grøn PL; Klebe JG
    Acta Obstet Gynecol Scand; 2001 Sep; 80(9):803-6. PubMed ID: 11531629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic risk factor for the onset and progression of diabetic complication].
    Nakajima K; Tanaka Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():95-101. PubMed ID: 12430213
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients.
    Neugebauer S; Baba T; Watanabe T
    Lancet; 1998 Aug; 352(9126):454. PubMed ID: 9708759
    [No Abstract]   [Full Text] [Related]  

  • 15. No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy.
    Fujita H; Narita T; Meguro H; Ishii T; Hanyu O; Suzuki K; Kamoi K; Ito S
    J Diabetes Complications; 1999; 13(5-6):284-7. PubMed ID: 10765003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM.
    Arai K; Yamasaki Y; Kajimoto Y; Watada H; Umayahara Y; Kodama M; Sakamoto K; Hori M
    Diabetes; 1997 Dec; 46(12):2102-4. PubMed ID: 9392503
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population.
    Benes P; Kanková K; Muzík J; Groch L; Benedík J; Elbl L; Izakovicová-Hollá L; Vasků A; Znojil V; Vácha J
    Mol Genet Metab; 2001 Jun; 73(2):188-95. PubMed ID: 11386855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes.
    Santos KG; Tschiedel B; Schneider J; Souto K; Roisenberg I
    Diabetes Res Clin Pract; 2003 Aug; 61(2):133-6. PubMed ID: 12951282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemia, MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients.
    Mazza A; Giugliano D; Motti C; Cortese C; Andreotti F; Marra G; Nulli A
    Atherosclerosis; 2000 Mar; 149(1):223-4. PubMed ID: 10799016
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients.
    Shcherbak NS; Shutskaya ZV; Sheidina AM; Larionova VI; Schwartz EI
    Mol Genet Metab; 1999 Nov; 68(3):375-8. PubMed ID: 10562465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.